You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR MAPRACORAT


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for Mapracorat

Trial ID Title Status Sponsor Phase Summary
NCT00905450 ↗ Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery Completed Bausch & Lomb Incorporated Phase 2 This clinical study is being conducted to identify the most effective drug concentration and dose frequency of BOL-303242-X (Mapracorat) ophthalmic suspension, for the treatment of inflammation following cataract surgery.
NCT01228513 ↗ Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD) Completed Bayer Phase 2 The purpose of this study is to evaluate the efficacy and safety of three concentrations of a development drug compared to placebo in the treatment of atopic dermatitis.
NCT01230125 ↗ Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery Completed Bausch & Lomb Incorporated Phase 3 The objective of this clinical study is to compare the safety and efficacy of Mapracorat Ophthalmic Suspension, 3% to vehicle for the treatment of postoperative inflammation and pain following cataract surgery.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Mapracorat

Condition Name

Condition Name for
Intervention Trials
Cataract 5
Inflammation 4
Atopic Dermatitis 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Cataract 5
Inflammation 5
Eczema 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Mapracorat

Trials by Country

Trials by Country for
Location Trials
United States 17
Germany 2
Japan 2
South Africa 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
New York 8
Idaho 1
Hawaii 1
California 1
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Mapracorat

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 4
Phase 2 6
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Completed 11
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Mapracorat

Sponsor Name

Sponsor Name for
Sponsor Trials
Bausch & Lomb Incorporated 7
Bayer 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.